» Articles » PMID: 34899932

Apolipoprotein B Gene Mutation Related to Familial Hypercholesterolemia in an Iranian Population: With or Without Hypothyroidism

Abstract

Background: Familial hypercholesterolemia (FH) leads to elevated low-density lipoprotein cholesterol (LDL-C) levels in plasma. Mutations of its related gene; apolipoprotein B (APOB) is seen in about two percent of the patient with FH. Thyroid disease is usually part of the exclusion criteria for the detection of FH which alters the lipid profile. We evaluated mutations in the gene in patients with high LDL-C levels.

Materials And Methods: Patients aged between 2 and 80 years with at least one LDL-C level of more than 190 mg/dl were selected (120 patients) from Isfahan Laboratories. Blood samples were obtained from all patients. Genomic DNA was extracted. Primer sequences were designed by Oligo 7.60 to amplify the desired 844 bp region of exon 26 of the containing and variants associated with FH.

Results: Overall, two patients showed a heterozygous form of a common pathogenic variant in exon 26 named c. 10579 C > T (R3500W, cDNA.10707), and one patient was hypothyroidism. We also recognized another nonpathognomonic variant c. 10913G > A (rs1801701, cDNA.11041) in 13 patients, two of them were hypothyroidism.

Conclusion: This study for the first time shows the coexistence of mutation in hypothyroidism, which emphasis screening of patients with hypothyroid for FH detection.

Citing Articles

Familial Hypercholesterolemia (FH) in Iran: Findings from the Four-Year FH Registry.

Vaseghi G, Taheri M, Heshmat-Ghahdarijani K, Rayati M, Zarfeshani S, Pourmoghaddas A J Lipids. 2021; 2021:9913969.

PMID: 34221513 PMC: 8213494. DOI: 10.1155/2021/9913969.

References
1.
Innerarity T, Weisgraber K, Arnold K, Mahley R, Krauss R, Vega G . Familial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor binding. Proc Natl Acad Sci U S A. 1987; 84(19):6919-23. PMC: 299196. DOI: 10.1073/pnas.84.19.6919. View

2.
Repas T, Tanner J . Preventing early cardiovascular death in patients with familial hypercholesterolemia. J Am Osteopath Assoc. 2014; 114(2):99-108. DOI: 10.7556/jaoa.2014.023. View

3.
Taylor P, Razvi S, Pearce S, Dayan C . Clinical review: A review of the clinical consequences of variation in thyroid function within the reference range. J Clin Endocrinol Metab. 2013; 98(9):3562-71. DOI: 10.1210/jc.2013-1315. View

4.
Illingworth D, McClung M, Connor W, Alaupovic P . Familial hypercholesterolaemia and primary hypothyroidism: coexistence of both disorders in a young woman with severe hypercholesterolaemia. Clin Endocrinol (Oxf). 1981; 14(2):145-52. DOI: 10.1111/j.1365-2265.1981.tb00609.x. View

5.
Austin M, Hutter C, Zimmern R, Humphries S . Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review. Am J Epidemiol. 2004; 160(5):407-20. DOI: 10.1093/aje/kwh236. View